Lv4
520 积分 2025-10-18 加入
Multicenter, Retrospective, observational study to evaluate the real-world use and effectiveness of a fixed-ratio combination of insulin degludec/liraglutide (IDegLira) in the Pakistani population with Type-2 diabetes (T2D)
6小时前
已完结
Switching from insulin injections to degludec/liraglutide in older frail persons: 6-month body composition remodelling
1天前
已完结
The change in Fibrosis‐4 index in Japanese patients with type 2 diabetes treated by a fixed‐ratio combination therapy of insulin degludec and liraglutide: A retrospective observational study
1天前
已完结
Once-Weekly Insulin Icodec vs Once-Daily Insulin Degludec in Adults With Insulin-Naive Type 2 Diabetes
4天前
已完结
Insulin Efsitora versus Degludec in Type 2 Diabetes without Previous Insulin Treatment
4天前
已完结
Once-Weekly Insulin Icodec vs Once-Daily Insulin Degludec in Adults With Insulin-Naive Type 2 Diabetes
4天前
已完结
Efficacy of once-weekly tirzepatide versus once-daily insulin degludec on glycaemic control measured by continuous glucose monitoring in adults with type 2 diabetes (SURPASS-3 CGM): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial
4天前
已完结
Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement
4天前
求助中
Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement
4天前
已完结
Treating a type 2 diabetic patient with impaired pancreatic islet function by personalized endoderm stem cell-derived islet tissue
1个月前
已完结
皖公网安备34019202002308
